Table 2.

Day-to-day and multicenter reproducibility of quantitating malignant myeloma cells using real-time IgH ASO-PCR or a limiting dilution assay

Patient Center Quantitation method No.analysesType of variation Input tumor cells (no.)Calculated tumor cells (no.) ASO-PCR variationControl PCR variation Total variationAverage per patient Average total
        Variation coefficient  
6  E  Limiting dilution  3  Day-to-day 9.6  10.1  0.24  0.56  0.61  
6  C  Limiting dilution  3  Day-to-day  9.6  13.7  0.32  0.92 0.97  
6  A  Real time PCR  4  Day-to-day  9.6 12.6  0.15  0.26  0.30  
6  E, C, G, U  Limiting dilution  Single  Multicenter (4)  9.6  11  0.24 0.72  0.76  
6  E, C, G, U  Limiting dilution  Triplo 5  Multicenter (4)  9.6  10.7  0.11  0.44  0.45  
E  Limiting dilution  3  Day-to-day  1600  2306 0.09  1.04  1.04  0.83  
6  C  Limiting dilution 3  Day-to-day  1600  695  0.65  0.84  1.06 1.02  
6  A  Real-time PCR  4  Day-to-day  1600 1890  0.32  0.14  0.35  0.33  
6  E, C, G, U Limiting dilution  Single  Multicenter (4)  1608  1287 0.50  0.89  1.02  0.89  
6  E, C, G, U  Limiting dilution  Triplo 5  Multicenter (4)  1608  1701  0.45 0.49  0.67  0.56  
H  E  Limiting dilution  Day-to-day  56  54  0.64  0.49  0.81  
H  Limiting dilution  3  Day-to-day  56  26  0.28 0.22  0.36  
H  A  Real-time PCR  4  Day-to-day 56  33  0.46  0.14  0.48  
H  E, C, G, U Limiting dilution  Single  Multicenter (4)  56  45 0.73  0.50  0.89  
H  E, C, G, U  Limiting dilution Triplo 5  Multicenter (4)  56  45  0.55  0.37 0.66  
H  E  Limiting dilution  3  Day-to-day  560 866  0.40  0.33  0.52  0.67  0.75  
H  Limiting dilution  3  Day-to-day  560  956  0.56 0.04  0.56  0.46  0.74  
H  A  Real-time PCR  Day-to-day  560  1702  0.27  0.10  0.29  0.39 0.36  
H  E, C, G, U  Limiting dilution  Single Multicenter (4)  560  993  0.43  0.44  0.62  0.76 0.83  
H  E, C, G, U  Limiting dilution  Triplo 5 Multicenter (4)  560  990  0.34  0.44  0.56  0.61 0.59 
Patient Center Quantitation method No.analysesType of variation Input tumor cells (no.)Calculated tumor cells (no.) ASO-PCR variationControl PCR variation Total variationAverage per patient Average total
        Variation coefficient  
6  E  Limiting dilution  3  Day-to-day 9.6  10.1  0.24  0.56  0.61  
6  C  Limiting dilution  3  Day-to-day  9.6  13.7  0.32  0.92 0.97  
6  A  Real time PCR  4  Day-to-day  9.6 12.6  0.15  0.26  0.30  
6  E, C, G, U  Limiting dilution  Single  Multicenter (4)  9.6  11  0.24 0.72  0.76  
6  E, C, G, U  Limiting dilution  Triplo 5  Multicenter (4)  9.6  10.7  0.11  0.44  0.45  
E  Limiting dilution  3  Day-to-day  1600  2306 0.09  1.04  1.04  0.83  
6  C  Limiting dilution 3  Day-to-day  1600  695  0.65  0.84  1.06 1.02  
6  A  Real-time PCR  4  Day-to-day  1600 1890  0.32  0.14  0.35  0.33  
6  E, C, G, U Limiting dilution  Single  Multicenter (4)  1608  1287 0.50  0.89  1.02  0.89  
6  E, C, G, U  Limiting dilution  Triplo 5  Multicenter (4)  1608  1701  0.45 0.49  0.67  0.56  
H  E  Limiting dilution  Day-to-day  56  54  0.64  0.49  0.81  
H  Limiting dilution  3  Day-to-day  56  26  0.28 0.22  0.36  
H  A  Real-time PCR  4  Day-to-day 56  33  0.46  0.14  0.48  
H  E, C, G, U Limiting dilution  Single  Multicenter (4)  56  45 0.73  0.50  0.89  
H  E, C, G, U  Limiting dilution Triplo 5  Multicenter (4)  56  45  0.55  0.37 0.66  
H  E  Limiting dilution  3  Day-to-day  560 866  0.40  0.33  0.52  0.67  0.75  
H  Limiting dilution  3  Day-to-day  560  956  0.56 0.04  0.56  0.46  0.74  
H  A  Real-time PCR  Day-to-day  560  1702  0.27  0.10  0.29  0.39 0.36  
H  E, C, G, U  Limiting dilution  Single Multicenter (4)  560  993  0.43  0.44  0.62  0.76 0.83  
H  E, C, G, U  Limiting dilution  Triplo 5 Multicenter (4)  560  990  0.34  0.44  0.56  0.61 0.59 

The factor-range expresses the quotient of actual maximal and minimal values found in the quantitation assays.

Triplo 5, mean of 5 PCR reactions; whole procedure is repeated 3 times (15 PCR).

Close Modal

or Create an Account

Close Modal
Close Modal